Medical technologies

The TECNIS PC-IOL Portfolio Powered by InteliLight delivers the best* contrast and low-light performance across the PC-IOL category1,2,3 TECNIS Symfony OptiBlue is now available in the U.S. and select countries in EMEA

The OCTARAY™ Mapping Catheter with TRUEref™ Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias[1],[2],[‡]

Real-world evidence study demonstrates majority of patients with mCSPC achieved over 90 percent decline in PSA by six months after initiation of ERLEADA® Rapid and deep PSA decline is associated with improved health-related quality of life in advanced prostate cancer as shown by separate post-hoc analysis of patient-reported outcomes from Phase 3 SPARTAN and TITAN studies

Implant provides the natural feel patients desire with increased form stability to shape the breast Recent study shows patients and surgeons both preferred the MENTOR® MemoryGel BOOST™ Breast Implant as feeling more like a natural breast versus another leading brand

Collaboration will support a secure, compliant and unified platform to improve customer experience and patient outcomes Combined expertise from both companies poised to make a significant impact in MedTech

Data presented at ASH 2021 show 83 percent of patients achieved a stringent complete response at median follow-up of 22-months 92 percent of evaluable patients achieved minimal residual disease negativity, with progression-free survival and overall survival sustained in those patients for ≥6 and ≥12 months

Patients at Sydney’s Mater Hospital are the first in Australia to experience the next generation in robotic assisted surgery. Mater’s surgical team trained on the VELYSTM Robotic-Assisted Solution using the Johnson & Johnson Institute’s first-of-its-kind in Australia Mobile Training Lab and Virtual Reality technology. VELYS Robotic-Assisted Solution helps address challenges cited with robotic assisted technologies on operational efficiencies by helping to simplify surgeons’ existing workflow.[i][ii]

DePuy Synthes and the Johnson & Johnson Institute are rolling out a first-of-its-kind in Australia mobile training experience for surgeons and hospital staff to provide on-site, hands-on training for the VELYSTM Robotic-Assisted Solution. The mobile training lab brings innovative training solutions – incorporating virtual reality and novel surgical simulation technologies – to surgeons and their surgical teams at their clinical practice. The VELYS™ Robotic-Assisted Solution, indicated for use with the ATTUNE® Knee System for total knee arthroplasty, has recently been included on the Australian Register of Therapeutic Goods (ARTG).

CHRYSALIS-2 findings presented at ESMO Annual Congress 2021 suggest that RYBREVANT® and lazertinib combination has encouraging anti-tumor activity in this population that has exhausted standard-of-care treatments